(917) 310-3371
HIPAA-aware
Private addiction medicine visits and careful communication.
Confidential Suboxone treatment that fits your life
Same-day evaluation when available, online and in-person support, insurance and Medicaid review, and no judgment for people dealing with opioid dependence, fentanyl exposure, or pain-pill misuse.
Suboxone treatment combines buprenorphine and naloxone with medical follow-up. The goal is to reduce withdrawal symptoms, cravings, relapse risk, and overdose danger while helping daily life become more stable.
Medication decisions require clinical review. A medication that helps one person may be unsafe for another because of recent substance use, withdrawal timing, pregnancy, liver or kidney disease, seizure history, opioid exposure, psychiatric symptoms, current prescriptions, or overdose risk.
Recovery support should be practical
Medication can help with withdrawal and cravings, but follow-up, safety planning, and mental-health support keep the plan grounded.
Licensed clinicians
Suboxone decisions require medical review and follow-up.
Coordinated care
Medical, behavioral-health, pharmacy, and follow-up needs can be connected in one plan.
Hybrid care
Telehealth plus local NYC and Long Island clinic access.
What is Suboxone treatment?
Suboxone is a buprenorphine-naloxone medication used as part of medication treatment for opioid-use disorder. It can reduce cravings and withdrawal symptoms when started at the right time and monitored by a clinician.
Buprenorphine
A partial opioid agonist that can reduce withdrawal and cravings while having a ceiling effect that improves safety when used correctly.
Naloxone
Included to discourage misuse. It does not replace overdose-reversal naloxone that families may carry for emergencies.
Medical follow-up
Medication is paired with follow-up visits, safety review, counseling coordination, testing when useful, and relapse-prevention planning.
Signs medication support may help
- Fear of withdrawal or repeated withdrawal symptoms.
- Cravings that keep pulling opioid use back into daily life.
- Fentanyl, heroin, oxycodone, hydrocodone, Vicodin, Percocet, codeine, or OxyContin use that feels hard to stop.
- Repeated attempts to quit without enough support.
- Hiding use, missing work or family responsibilities, or needing opioids to feel normal.
- Recent relapse after detox, rehab, jail, hospital care, or a period of stability.
Am I eligible for Suboxone treatment?
Most people start with a clinical review. These questions help the provider understand timing and safety before deciding whether medication is appropriate.
Are you having withdrawal symptoms?
Timing helps decide whether medication can start safely.
Have you used opioids recently?
Recent fentanyl, heroin, or pain-pill use affects the plan.
Do you want discreet treatment?
Private telehealth and local follow-up may reduce barriers.
Do you have insurance or Medicaid?
Coverage can be checked before treatment moves forward.
How Suboxone treatment works
1. Book a private visit
Choose telehealth or local care when appropriate, share urgent timing needs, and bring medication, insurance, and pharmacy information.
2. Meet your provider
Review opioid use, withdrawal symptoms, medical history, mental health, medication safety, and recovery goals without judgment.
3. Start a treatment plan
If eligible, medication can be planned with education, pharmacy coordination, follow-up timing, and safety guidance.
4. Keep support in place
Follow-up visits review cravings, side effects, dose stability, testing, relapse risk, counseling, and longer-term recovery needs.
Why choose Nao Medical instead
Nao Medical vs online-only care
Nao offers telehealth when appropriate plus local NYC and Long Island access when testing, in-person review, or follow-up is needed.
Nao Medical vs emergency rooms
Emergency rooms are essential for crisis care, but ongoing medication treatment usually needs repeat follow-up and outpatient planning.
Nao Medical vs traditional rehab
Residential rehab can be right for some patients, while office-based medication care can fit people who need treatment around work, family, or school.
Nao Medical's OASAS-certified outpatient program
Nao focuses on office-based buprenorphine and naltrexone pathways, with counseling and recovery support available through its OASAS-certified outpatient program.
Insurance and pricing
Insurance
Coverage varies by visit type, medication, pharmacy benefit, lab testing, counseling, and prior authorization. The team can verify the relevant benefits before treatment begins.
Medicaid
Many Medicaid plans can be reviewed for addiction medicine visits, medication coverage, and testing needs.
Self-pay
Current self-pay visit, testing, and follow-up fees are confirmed before treatment moves forward. Medication and pharmacy costs are separate.
No surprise plan
Visit, screening, medication, pharmacy, and follow-up costs are reviewed before the next step whenever possible.
Suboxone treatment across New York
Local care is available in Queens, Brooklyn, the Bronx, Manhattan, Nassau County, and Long Island, with telehealth support when appropriate.
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local medication support Get directions
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local medication support Get directions
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local medication support Get directions
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local medication support Get directions
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local medication support Get directions
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local medication support Get directions
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local medication support Get directions
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A Manhattan access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local medication support Get directions
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local medication support Get directionsFamily support matters
Family members often look for help before the patient is ready to talk. Support can include encouraging a private medical visit, avoiding shame, keeping naloxone available, helping with transportation, asking about insurance, and recognizing when emergency care is needed.
Recovery is not a race. Medication treatment can help create enough stability for counseling, sleep, work, family life, and mental-health care to become more manageable.
Related medication options
Buprenorphine treatment
Medication review for opioid withdrawal timing, cravings, stabilization, and follow-up.
Sublocade injection
Monthly injectable buprenorphine review for eligible patients after buprenorphine tolerability and the appropriate transition plan are confirmed.
Vivitrol and naltrexone
Naltrexone options for alcohol-use disorder and opioid relapse prevention after opioid-free planning.
Alcohol medication
Naltrexone, acamprosate, and disulfiram discussion for alcohol-use disorder when appropriate.
Counseling
Medication works best when paired with counseling, follow-up, relapse planning, and mental-health support.
Family support
Support for relatives who need help encouraging care without shame or coercion.
Suboxone treatment FAQs
Suboxone is a buprenorphine-naloxone medication used to treat opioid-use disorder. Buprenorphine helps reduce cravings and withdrawal symptoms, while naloxone is included to discourage misuse.
Buprenorphine-naloxone medications are FDA-approved for opioid-use disorder. A provider still needs to decide whether the medication is appropriate for the patient.
Care usually starts with assessment, withdrawal timing review, medication education, prescription planning when eligible, follow-up visits, and ongoing relapse-prevention support.
Possibly. Same-day evaluation may be available, but medication timing depends on recent opioid use, withdrawal symptoms, fentanyl exposure, safety, and clinical review.
Some care may happen through telehealth when clinically and legally appropriate. In-person care may still be needed for testing, vital signs, injections, or complex symptoms.
Timing varies. It is usually started when withdrawal timing is appropriate so the medication can reduce symptoms without causing precipitated withdrawal.
When taken as prescribed for opioid-use disorder, Suboxone is intended to reduce withdrawal and cravings, not create intoxication. Any unusual sedation or impairment should be reported immediately.
Buprenorphine can cause physical dependence, but medically supervised treatment for opioid-use disorder is different from uncontrolled opioid use. The goal is stability, reduced overdose risk, and recovery support.
Medication treatment under medical supervision is generally much safer than uncontrolled opioid use, especially when paired with follow-up and overdose-risk planning.
Recent fentanyl use can make medication timing more nuanced. The provider reviews timing, withdrawal symptoms, prior buprenorphine experience, and safety before planning a start.
Fentanyl, heroin, oxycodone, OxyContin, hydrocodone, Vicodin, Percocet, codeine, and other opioids can be involved in opioid-use disorder.
No. Those are opioid pain medications and can be part of the problem. They are not opioid-use-disorder treatment medications.
Buprenorphine is an FDA-approved medication for opioid-use disorder. It can reduce withdrawal symptoms and cravings when used under medical supervision.
Suboxone is one buprenorphine-naloxone product. Buprenorphine treatment can also refer more broadly to buprenorphine-based care.
Sublocade is a monthly injectable buprenorphine option for eligible patients after buprenorphine tolerability and the appropriate transition plan are confirmed treatment.
Vivitrol is extended-release injectable naltrexone. For opioid relapse prevention, opioid-free planning is required before starting.
That depends on the medication. Vivitrol requires opioid-free planning. Buprenorphine depends on timing and withdrawal symptoms. Severe withdrawal may need a higher level of care.
Some clinicians can prescribe buprenorphine when they are appropriately licensed and the visit is clinically appropriate. The visit still requires assessment and follow-up planning.
Many Medicaid plans cover addiction medicine visits and medications, but coverage details vary by plan, medication, pharmacy benefit, testing, and authorization requirements.
Cost depends on insurance and visit type. Current self-pay visit, testing, and follow-up fees are confirmed before treatment moves forward. Medication and pharmacy costs are separate. Medication copays and pharmacy rules are separate and depend on the plan.
Nao Medical handles addiction medicine visits with privacy and respect. Insurance, records, and communication preferences can be discussed before treatment moves forward.
Many patients continue working during treatment. Any sedation, impairment, job safety requirement, driving concern, or medication side effect should be reviewed with the provider.
The provider reviews opioid use history, withdrawal timing, medical history, medications, mental health, overdose risk, pregnancy questions when relevant, and treatment goals.
Testing may be part of care when clinically useful for safety, medication monitoring, or documentation. The team explains what is needed and why.
Treatment duration is individualized. Some patients need shorter stabilization, while others benefit from longer maintenance and gradual changes over time.
Yes, if clinically appropriate. A relapse should trigger a safety review, not shame. The plan may adjust medication timing, follow-up, counseling, or overdose prevention.
Family members can help with support, safety planning, transportation, and encouragement, but the patient's privacy and consent still matter.
Yes. Medication often works best with counseling, relapse-prevention planning, mental-health care, and follow-up.
Pregnancy requires individualized addiction and obstetric care. Do not start, stop, or change medication without a clinician who understands both pregnancy and opioid-use disorder.
Call 911 or go to the nearest emergency room for overdose, severe withdrawal, chest pain, seizure, confusion, loss of consciousness, severe intoxication, suicidal thoughts, or any situation that feels medically unsafe.
Related treatment paths
Compare medication, visit, and follow-up options, then choose the care path that fits your current needs.
Online Suboxone treatment
Telehealth evaluation when appropriate, with local clinic support when an in-person step is needed.
Same-day Suboxone evaluation
Fast assessment without promising that medication can or should start before timing and safety are reviewed.
Buprenorphine treatment
Evaluation of oral and long-acting buprenorphine options for opioid use disorder.
Kratom dependence treatment
Assessment of Kratom leaf, extracts, or concentrated 7-OH use; withdrawal and safety review; counseling options; and individualized medication evaluation. Suboxone is not approved specifically for Kratom dependence, so treatment is not automatic.
Sublocade injections
Monthly extended-release buprenorphine evaluation, access coordination, and in-clinic administration planning.
Brixadi injections
Weekly or monthly extended-release buprenorphine evaluation, coverage coordination, and treatment planning.
Vivitrol treatment
Extended-release naltrexone evaluation for opioid or alcohol use disorder when clinically appropriate.
Clinical sources
These public clinical and regulatory sources were checked on August 1, 2026. They support the general information and do not replace an individual medical evaluation.
SAMHSA: Buprenorphine
How buprenorphine works and how it is used for opioid use disorder.
SAMHSA: Quick Start Guide
Clinical initiation, withdrawal timing, assessment, and follow-up guidance.
New York OASAS: Medications for OUD
New York guidance on office-based opioid-use-disorder medication and access.
Focused care or a more supported outpatient program
Nao Medical operates a New York State OASAS-certified outpatient addiction treatment program. The first visit can focus on the immediate clinical question and medication planning when relevant, or the care plan can include counseling, recovery support, and closer follow-up when that is wanted or clinically recommended.
Focused clinical visits
Patients can request a private evaluation centered on the immediate concern, prescribing or injection planning when applicable, monitoring, and practical next steps. Medication is never automatic; eligibility and safety still require clinician review.
Counseling is available
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Confidential intake first
After scheduling, complete the confidential addiction intake form when it is sent. It helps the team review current substance use, prior treatment, medications, insurance, and the safest visit type.
Nao Medical accepts Medicaid and many major insurance plans, including Medicare, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare and UnitedHealthcare Community Plan, EmblemHealth, Aetna, Cigna, and Blue Cross Blue Shield. Coverage varies by visit, medication, pharmacy benefit, testing, counseling, and prior authorization. Review addiction-treatment insurance support.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.